1-5 of 5
Douglas Yee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds

Free
Jie Ying Chan, Benjamin J. Hackel, Douglas Yee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (7): 1324–1334.
https://doi.org/10.1158/1535-7163.MCT-16-0685
Published: 04 July 2017
View articletitled, Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds
Open the PDF for Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds in another window
Includes: Supplementary data
Journal Articles

Abstract C61: Non-homogeneous drug penetrance of veliparib measured in triple negative breast tumors

Free
Imke H. Bartelink, Brendan Prideaux, Gregor Krings, Lisa Wilmes, Pei R.E. Lee, Byron Hann, Jean-Philippe Coppé, Diane Heditsian, Lamorna Swigart-Brown, Ella F. Jones, Sergey Magnitsky, Ron Keizer, Laura Esserman, Weiming Ruan, Alan Wu, Douglas Yee, Veronique Dartois, Denise Wolf, Rada Savic, Laura vantVeer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C61.
https://doi.org/10.1158/1535-7163.TARG-15-C61
Published: 01 December 2015
View articletitled, Abstract C61: Non-homogeneous drug penetrance of veliparib measured in triple negative breast tumors
Journal Articles

Abstract CN07-02: Disrupting insulin‐like growth factor signaling with monoclonal antibodies

Free
Douglas Yee, Dedra H. Fagan, Xihong Zhang, Annabell S. Oh, Kelly LaPara, Marc Becker, Deepali Sachdev, Hua Zhang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): CN07-02.
https://doi.org/10.1158/1535-7163.TARG-09-CN07-02
Published: 10 December 2009
View articletitled, Abstract CN07-02: Disrupting insulin‐like growth factor signaling with monoclonal antibodies
Journal Articles

Disrupting insulin-like growth factor signaling as a potential cancer therapy

Free
Deepali Sachdev, Douglas Yee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (1): 1–12.
https://doi.org/10.1158/1535-7163.MCT-06-0080
Published: 19 January 2007
View articletitled, Disrupting insulin-like growth factor signaling as a potential cancer therapy
Open the PDF for Disrupting insulin-like growth factor signaling as a potential cancer therapy in another window
Journal Articles

Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells

Free
Mariya Farooqui, Zhen H. Geng, Elliot J. Stephenson, Nurulain Zaveri, Douglas Yee, Kalpna Gupta
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (3): 611–620.
https://doi.org/10.1158/1535-7163.MCT-05-0016
Published: 16 March 2006
View articletitled, Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells
Open the PDF for Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells in another window